Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin A | 3 | 2022 | 79 | 1.800 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2021 | 114 | 1.770 |
Why?
|
| Gastrointestinal Microbiome | 6 | 2020 | 121 | 1.720 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2022 | 529 | 1.700 |
Why?
|
| Centrioles | 3 | 2015 | 7 | 1.370 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2022 | 756 | 1.360 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 230 | 1.180 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2022 | 199 | 1.040 |
Why?
|
| beta-Glucans | 3 | 2020 | 18 | 1.020 |
Why?
|
| Autoimmunity | 4 | 2020 | 118 | 1.020 |
Why?
|
| Immune Tolerance | 3 | 2022 | 114 | 1.010 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2022 | 195 | 0.880 |
Why?
|
| Dendritic Cells | 3 | 2022 | 201 | 0.810 |
Why?
|
| Transport Vesicles | 1 | 2021 | 5 | 0.790 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2020 | 172 | 0.760 |
Why?
|
| Lysosomes | 1 | 2021 | 136 | 0.740 |
Why?
|
| Hyperglycemia | 1 | 2022 | 158 | 0.730 |
Why?
|
| Colitis | 2 | 2020 | 156 | 0.690 |
Why?
|
| Bacteroidetes | 1 | 2019 | 5 | 0.670 |
Why?
|
| Polysaccharides | 2 | 2020 | 176 | 0.660 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 27 | 0.660 |
Why?
|
| Antigens, Nuclear | 3 | 2022 | 24 | 0.600 |
Why?
|
| Mice | 15 | 2022 | 8474 | 0.560 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 597 | 0.560 |
Why?
|
| Ligands | 3 | 2022 | 317 | 0.530 |
Why?
|
| Feces | 5 | 2022 | 88 | 0.500 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2016 | 135 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 6 | 2022 | 2791 | 0.430 |
Why?
|
| Lectins, C-Type | 3 | 2019 | 39 | 0.410 |
Why?
|
| Animals | 17 | 2022 | 20880 | 0.410 |
Why?
|
| HeLa Cells | 3 | 2021 | 237 | 0.400 |
Why?
|
| Tubulin | 1 | 2011 | 60 | 0.380 |
Why?
|
| CTLA-4 Antigen | 2 | 2022 | 45 | 0.380 |
Why?
|
| HEK293 Cells | 3 | 2021 | 326 | 0.380 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 72 | 0.370 |
Why?
|
| Antigen Presentation | 2 | 2022 | 76 | 0.370 |
Why?
|
| Drinking Water | 3 | 2015 | 33 | 0.360 |
Why?
|
| Gastrointestinal Tract | 3 | 2015 | 63 | 0.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 216 | 0.360 |
Why?
|
| Immunity | 2 | 2020 | 67 | 0.340 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 94 | 0.340 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2009 | 6 | 0.330 |
Why?
|
| Interleukin-10 | 2 | 2019 | 144 | 0.320 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 2550 | 0.290 |
Why?
|
| Green Fluorescent Proteins | 2 | 2020 | 200 | 0.290 |
Why?
|
| NF-kappa B | 1 | 2009 | 432 | 0.280 |
Why?
|
| Mice, Inbred NOD | 4 | 2021 | 138 | 0.270 |
Why?
|
| Bacteria | 3 | 2020 | 193 | 0.260 |
Why?
|
| Immunity, Innate | 2 | 2014 | 156 | 0.230 |
Why?
|
| Prebiotics | 2 | 2020 | 10 | 0.220 |
Why?
|
| Permeability | 1 | 2022 | 131 | 0.210 |
Why?
|
| Gastrins | 1 | 2021 | 27 | 0.200 |
Why?
|
| Humans | 12 | 2022 | 68549 | 0.200 |
Why?
|
| Ubiquitination | 2 | 2015 | 85 | 0.200 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2022 | 118 | 0.200 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 219 | 0.200 |
Why?
|
| Multivesicular Bodies | 1 | 2021 | 3 | 0.200 |
Why?
|
| Autoantibodies | 2 | 2022 | 434 | 0.200 |
Why?
|
| Phosphoproteins | 2 | 2014 | 202 | 0.200 |
Why?
|
| Endosomes | 1 | 2021 | 45 | 0.190 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 87 | 0.190 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2021 | 63 | 0.190 |
Why?
|
| Endocytosis | 1 | 2021 | 113 | 0.190 |
Why?
|
| Microalgae | 1 | 2020 | 5 | 0.180 |
Why?
|
| Glucans | 1 | 2020 | 12 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 8 | 0.180 |
Why?
|
| Protein Transport | 1 | 2021 | 280 | 0.180 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 35 | 0.180 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 88 | 0.180 |
Why?
|
| Protein Interaction Mapping | 2 | 2011 | 62 | 0.180 |
Why?
|
| Protein Binding | 2 | 2014 | 1027 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 1851 | 0.170 |
Why?
|
| ErbB Receptors | 1 | 2021 | 239 | 0.170 |
Why?
|
| Intestines | 1 | 2020 | 114 | 0.170 |
Why?
|
| Biomarkers | 2 | 2022 | 1593 | 0.170 |
Why?
|
| Antigens | 1 | 2019 | 90 | 0.170 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 30 | 0.170 |
Why?
|
| Retinal Dehydrogenase | 1 | 2019 | 10 | 0.170 |
Why?
|
| Phenotype | 2 | 2020 | 946 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2019 | 35 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 87 | 0.160 |
Why?
|
| Cell Line | 2 | 2015 | 1752 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 226 | 0.150 |
Why?
|
| Isoenzymes | 1 | 2019 | 308 | 0.150 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 397 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 2 | 2014 | 41 | 0.150 |
Why?
|
| Female | 9 | 2022 | 38021 | 0.140 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 95 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2016 | 132 | 0.130 |
Why?
|
| Apoptosis | 2 | 2016 | 1641 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 69 | 0.120 |
Why?
|
| Fungal Polysaccharides | 1 | 2014 | 3 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 34 | 0.120 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 266 | 0.120 |
Why?
|
| Microbiota | 1 | 2015 | 79 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 2014 | 35 | 0.120 |
Why?
|
| Disease Progression | 4 | 2020 | 1037 | 0.120 |
Why?
|
| Male | 6 | 2022 | 37283 | 0.120 |
Why?
|
| Inflammation | 1 | 2020 | 1030 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2015 | 235 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2014 | 357 | 0.110 |
Why?
|
| Lupus Nephritis | 1 | 2015 | 193 | 0.110 |
Why?
|
| Cytokines | 5 | 2015 | 866 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 322 | 0.110 |
Why?
|
| Cell Division | 1 | 2014 | 541 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 682 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 434 | 0.100 |
Why?
|
| Transfection | 2 | 2011 | 782 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 100 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 57 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2011 | 57 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 282 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2011 | 71 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 266 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2019 | 2689 | 0.090 |
Why?
|
| RING Finger Domains | 1 | 2009 | 1 | 0.080 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2009 | 14 | 0.080 |
Why?
|
| Jurkat Cells | 1 | 2009 | 59 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 40 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 61 | 0.080 |
Why?
|
| Lysine | 1 | 2009 | 96 | 0.080 |
Why?
|
| Lymphoid Tissue | 2 | 2020 | 30 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 244 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 1860 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 174 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 2 | 2015 | 171 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2015 | 85 | 0.060 |
Why?
|
| Cisplatin | 1 | 2005 | 192 | 0.060 |
Why?
|
| Sex Factors | 2 | 2020 | 1265 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 618 | 0.050 |
Why?
|
| Verrucomicrobia | 1 | 2020 | 3 | 0.050 |
Why?
|
| Metagenomics | 1 | 2020 | 11 | 0.050 |
Why?
|
| Metagenome | 1 | 2020 | 17 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2019 | 20 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 532 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 507 | 0.040 |
Why?
|
| Transcriptome | 1 | 2020 | 164 | 0.040 |
Why?
|
| L-Selectin | 1 | 2016 | 28 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 30 | 0.040 |
Why?
|
| Necrosis | 1 | 2016 | 239 | 0.030 |
Why?
|
| Cyanobacteria | 1 | 2015 | 4 | 0.030 |
Why?
|
| Bacteroides | 1 | 2015 | 7 | 0.030 |
Why?
|
| Lactobacillus | 1 | 2015 | 6 | 0.030 |
Why?
|
| Mice, Inbred NZB | 1 | 2015 | 37 | 0.030 |
Why?
|
| Clostridium | 1 | 2015 | 10 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 60 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 241 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2015 | 19 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 1533 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2015 | 41 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 53 | 0.030 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2015 | 25 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2015 | 110 | 0.030 |
Why?
|
| Zymosan | 1 | 2014 | 12 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2014 | 31 | 0.030 |
Why?
|
| Proteinuria | 1 | 2015 | 136 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 50 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 219 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 126 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2015 | 116 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 238 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2013 | 30 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 498 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 786 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1033 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2013 | 753 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 911 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 4655 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2005 | 73 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 136 | 0.020 |
Why?
|
| Caspases | 1 | 2005 | 194 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2005 | 233 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2005 | 332 | 0.010 |
Why?
|